Statistical validation of a threshold to discriminate flow-cytometry minimal residual disease (MRD) levels with prognostic significance in acute myeloid leukemia (AML).

被引：0
|
作者：
Buccisano, Francesco
Maurillo, Luca
Gattei, Valter
Del Poeta, Giovanni
Del Principe, Maria Ilaria
Panetta, Paola
Fraboni, Daniela
Consalvo, Maria Irno
Ottaviani, Licia
Renzi, Daniela
Faccia, Sabrina
Sarlo, Chiara
Lo Coco, Francesco
Amadori, Sergio
Venditti, Adriano
机构：
[1] Policlin Vergata, Rome, Italy
[2] Osped S Eugenio, Rome, Italy
[3] Ctr Riferimento Oncol, Clin & Expt Hematol Res Unit, IRCCS, I-33081 Aviano, Italy
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2299.2299
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2299
引用
收藏
页码：651A / 652A
页数：2
相关论文
共 50 条
  • [1] PROGNOSTIC SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE ASSESSED BY MULTIPARAMETRIC FLOW-CYTOMETRY IN CHILDHOOD ACUTE MYELOID LEUKEMIA
    Rizzati, F.
    Buldini, B.
    Rondelli, R.
    Masetti, R.
    Zangrando, A.
    Disaro, S.
    Scarparo, P.
    Bortoloso, E.
    Pession, A.
    Locatelli, F.
    Basso, G.
    HAEMATOLOGICA, 2014, 99 : 528 - 528
  • [2] AN EFFICIENT AND SIMPLE MULTIPARAMETER FLOW CYTOMETRY PROTOCOL TO DETECT MINIMAL RESIDUAL DISEASE (MRD) FOR ACUTE MYELOID LEUKEMIA (AML)
    Li, Ke
    Wang, Hui
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 356 - 357
  • [3] ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - DETECTION OF MINIMAL RESIDUAL DISEASE (MRD) AT FLOW-CYTOMETRY
    ORFAO, A
    CIUDAD, J
    LOPEZBERGES, MC
    LOPEZ, A
    VIDRIALES, B
    CABALLERO, MD
    VALVERDE, B
    GONZALEZ, M
    SANMIGUEL, JF
    LEUKEMIA & LYMPHOMA, 1994, 13 : 87 - 90
  • [4] Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)
    Rodriguez-Arboli, Eduardo
    Othus, Megan
    Freeman, Sylvie D.
    Buccisano, Francesco
    Ngai, Lok Lam
    Thomas, Ian
    Palmieri, Raffaele
    Cloos, Jacqueline
    Johnson, Sean
    Meddi, Elisa
    Russell, Nigel H.
    Venditti, Adriano
    Gradowska, Patrycja
    Ossenkoppele, Gert J.
    Lowenberg, Bob
    Walter, Roland B.
    LEUKEMIA, 2024, 38 (10) : 2266 - 2269
  • [5] Identification of Individualized Minimal Residual Disease in Acute Myeloid Leukemia By Flow Cytometry and Its Application of Prognostic Significance
    Sui, Jing-Ni
    Chen, Qiu-Sheng
    Zhang, Yun-Xiang
    Sheng, Yan
    Wu, Jing
    Li, Jun-Min
    Hu, Jiong
    Weng, Xiang-Qin
    Chen, Bing
    BLOOD, 2018, 132
  • [6] Prognostic Effect and Clinical Application of Early Measurable Residual Disease (MRD) By Flow Cytometry on De Novo Acute Myeloid Leukemia (AML)
    Zhang, Congxiao
    Gu, Runxia
    Zhou, Chunlin
    Li, Yan
    Liu, Yuntao
    Wei, Shuning
    Lin, Dong
    Gong, Benfa
    Liu, Kaiqi
    Fang, Qiuyun
    Gong, Xiaoyuan
    Qiu, Shaowei
    Liu, Bingcheng
    Wang, Ying
    Wei, Hui
    Mi, Yingchang
    Wang, Jianxiang
    BLOOD, 2022, 140 : 2030 - 2032
  • [7] DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA BY FLOW-CYTOMETRY
    VISSER, JWM
    MARTENS, ACM
    HAGENBEEK, A
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 468 : 268 - 275
  • [8] Predicting outcome based on minimal residual disease (MRD) using multiparameter flow cytometry (FC) in acute myeloid leukemia (AML) patients (Pts)
    Sardesai, Sagar D.
    Tan, Wei
    Ford, Laurie Ann
    Deeb, George
    Block, Anne Marie W.
    Sait, Sheila N. J.
    McCarthy, Philip L.
    Vigil, Carlos E.
    Griffiths, Elizabeth A.
    Thompson, James E.
    Wang, Eunice S.
    Wallace, Paul K.
    Wetzler, Meir
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Flow cytometry in acute myeloid leukemia and detection of minimal residual disease
    Cai, Qihui
    Lan, Haiqiang
    Yi, Deng
    Xian, Bojun
    Zidan, Luo
    Li, Jianqiao
    Liao, Zhaohong
    CLINICA CHIMICA ACTA, 2025, 564
  • [10] The Prognostic Significance of Measurable ("Minimal") Residual Disease in Acute Myeloid Leukemia
    Buccisano, Francesco
    Hourigan, Christopher S.
    Walter, Roland B.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (06) : 547 - 556
12345